We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| 1Life Healthcare Inc | NASDAQ:ONEM | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 16.47 | 22.00 | 16.54 | 0 | 00:00:00 |
From Jan 2022 to Jan 2025
NEW YORK, July 21, 2022 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by One Medical (NASDAQ: ONEM) and its board of directors concerning the proposed acquisition of the company by Amazon (NASDAQ: AMZN). Stockholders will receive $18.00 for each share of One Medical stock that they hold. The transaction is valued at approximately $3.9 billion.
If you are a stockholder of One Medical and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/onem/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View original content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-one-medical-301591379.html
SOURCE Rowley Law PLLC
Copyright 2022 PR Newswire
1 Year 1Life Healthcare Chart |
1 Month 1Life Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
